Travis J. Hollmann
Memorial Sloan Kettering Cancer Center
1 paper in the Anchorcite directory, published in 2014, cited 4,349 times in total.
ORCID profileResearch topics
- Cancer Immunotherapy and Biomarkers · 1 paper
- Immunotherapy and Immune Responses · 1 paper
- Cutaneous Melanoma Detection and Management · 1 paper
Frequent co-authors
- Alexandra Snyder · 1 paper
- Vladimir Makarov · 1 paper
- Taha Merghoub · 1 paper
- Jianda D. Yuan · 1 paper
- Jesse Meir Zaretsky · 1 paper
- Alexis Desrichard · 1 paper
- Logan A. Walsh · 1 paper
- Michael Andrew Postow · 1 paper
Papers
- Genetic Basis for Clinical Response to CTLA-4 Blockade in MelanomaNew England Journal of Medicine · 2014 · 4,349 citations
BACKGROUND: Immune checkpoint inhibitors are effective cancer treatments, but molecular determinants of clinical benefit are unknown. Ipilimumab and tremelimumab are antibodies against cytotoxic T-lymphocyte antigen 4 (CTLA-4). Anti-CTLA-4 treatment prolongs overall survival in patients with melanoma. CTLA-4 blockade activates T…
Metadata from OpenAlex (CC0).